Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 151 entries
Sorted by: Best Match Show Resources per page
Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.

Nature cell biology

Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, Fernández-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M, Zúñiga-García P, Graupera M, Bellmunt A, Pandya P, Lorente M, Martín-Martín N, Sutherland JD, Sanchez-Mosquera P, Bozal-Basterra L, Zabala-Letona A, Arruabarrena-Aristorena A, Berenguer A, Embade N, Ugalde-Olano A, Lacasa-Viscasillas I, Loizaga-Iriarte A, Unda-Urzaiz M, Schultz N, Aransay AM, Sanz-Moreno V, Barrio R, Velasco G, Pinton P, Cordon-Cardo C, Locasale JW, Gomis RR, Carracedo A.
PMID: 28659639
Nat Cell Biol. 2017 Jun 29;19(7):873. doi: 10.1038/ncb3558.

This corrects the article DOI: 10.1038/ncb3357.

Cite
Torrano V, Valcarcel-Jimenez L, Cortazar AR, et al. Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis. Nat Cell Biol. 2017;19(7):873doi: 10.1038/ncb3558.
Torrano, V., Valcarcel-Jimenez, L., Cortazar, A. R., Liu, X., Urosevic, J., Castillo-Martin, M., Fernández-Ruiz, S., Morciano, G., Caro-Maldonado, A., Guiu, M., Zúñiga-García, P., Graupera, M., Bellmunt, A., Pandya, P., Lorente, M., Martín-Martín, N., Sutherland, J. D., Sanchez-Mosquera, P., Bozal-Basterra, L., Zabala-Letona, A., Arruabarrena-Aristorena, A., Berenguer, A., Embade, N., Ugalde-Olano, A., Lacasa-Viscasillas, I., Loizaga-Iriarte, A., Unda-Urzaiz, M., Schultz, N., Aransay, A. M., Sanz-Moreno, V., Barrio, R., Velasco, G., Pinton, P., Cordon-Cardo, C., Locasale, J. W., Gomis, R. R., & Carracedo, A. (2017). Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis. Nature cell biology, 19(7), 873. https://doi.org/10.1038/ncb3558
Torrano, Veronica, et al. "Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis." Nature cell biology vol. 19,7 (2017): 873. doi: https://doi.org/10.1038/ncb3558
Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, Fernández-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M, Zúñiga-García P, Graupera M, Bellmunt A, Pandya P, Lorente M, Martín-Martín N, Sutherland JD, Sanchez-Mosquera P, Bozal-Basterra L, Zabala-Letona A, Arruabarrena-Aristorena A, Berenguer A, Embade N, Ugalde-Olano A, Lacasa-Viscasillas I, Loizaga-Iriarte A, Unda-Urzaiz M, Schultz N, Aransay AM, Sanz-Moreno V, Barrio R, Velasco G, Pinton P, Cordon-Cardo C, Locasale JW, Gomis RR, Carracedo A. Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis. Nat Cell Biol. 2017 Jun 29;19(7):873. doi: 10.1038/ncb3558. PMID: 28659639.
Copy Download .nbib Format: NLM
Alcohol and breast cancer tumor subtypes in a Spanish Cohort.

SpringerPlus

Gago-Dominguez M, Castelao JE, Gude F, Fernandez MP, Aguado-Barrera ME, Ponte SM, Redondo CM, Castelo ME, Dominguez AN, Garzón VM, Carracedo A, Martínez ME.
PMID: 26835221
Springerplus. 2016 Jan 16;5:39. doi: 10.1186/s40064-015-1630-2. eCollection 2016.

Although alcohol intake is an established risk factor for overall breast cancer, few studies have looked at the relationship between alcohol use and breast cancer risk by the four major subtypes of breast cancer and very few data exist...

Cite
Gago-Dominguez M, Castelao JE, Gude F, et al. Alcohol and breast cancer tumor subtypes in a Spanish Cohort. Springerplus. 2016;5:39doi: 10.1186/s40064-015-1630-2.
Gago-Dominguez, M., Castelao, J. E., Gude, F., Fernandez, M. P., Aguado-Barrera, M. E., Ponte, S. M., Redondo, C. M., Castelo, M. E., Dominguez, A. N., Garzón, V. M., Carracedo, A., & Martínez, M. E. (2016). Alcohol and breast cancer tumor subtypes in a Spanish Cohort. SpringerPlus, 539. https://doi.org/10.1186/s40064-015-1630-2
Gago-Dominguez, Manuela, et al. "Alcohol and breast cancer tumor subtypes in a Spanish Cohort." SpringerPlus vol. 5 (2016): 39. doi: https://doi.org/10.1186/s40064-015-1630-2
Gago-Dominguez M, Castelao JE, Gude F, Fernandez MP, Aguado-Barrera ME, Ponte SM, Redondo CM, Castelo ME, Dominguez AN, Garzón VM, Carracedo A, Martínez ME. Alcohol and breast cancer tumor subtypes in a Spanish Cohort. Springerplus. 2016 Jan 16;5:39. doi: 10.1186/s40064-015-1630-2. eCollection 2016. PMID: 26835221; PMCID: PMC4715100.
Copy Download .nbib Format: NLM
A 6q14.1-q15 microdeletion in a male patient with severe autistic disorder, lack of oral language, and dysmorphic features with concomitant presence of a maternally inherited Xp22.31 copy number gain.

Clinical case reports

Quintela I, Fernandez-Prieto M, Gomez-Guerrero L, Resches M, Eiris J, Barros F, Carracedo A.
PMID: 26185640
Clin Case Rep. 2015 Jun;3(6):415-23. doi: 10.1002/ccr3.255. Epub 2015 Apr 09.

We report on a male patient with severe autistic disorder, lack of oral language, and dysmorphic features who carries a rare interstitial microdeletion of 4.96 Mb at chromosome 6q14.1-q15. The patient also harbors a maternally inherited copy number gain...

Cite
Quintela I, Fernandez-Prieto M, Gomez-Guerrero L, et al. A 6q14.1-q15 microdeletion in a male patient with severe autistic disorder, lack of oral language, and dysmorphic features with concomitant presence of a maternally inherited Xp22.31 copy number gain. Clin Case Rep. 2015;3(6):415-23doi: 10.1002/ccr3.255.
Quintela, I., Fernandez-Prieto, M., Gomez-Guerrero, L., Resches, M., Eiris, J., Barros, F., & Carracedo, A. (2015). A 6q14.1-q15 microdeletion in a male patient with severe autistic disorder, lack of oral language, and dysmorphic features with concomitant presence of a maternally inherited Xp22.31 copy number gain. Clinical case reports, 3(6), 415-23. https://doi.org/10.1002/ccr3.255
Quintela, Ines, et al. "A 6q14.1-q15 microdeletion in a male patient with severe autistic disorder, lack of oral language, and dysmorphic features with concomitant presence of a maternally inherited Xp22.31 copy number gain." Clinical case reports vol. 3,6 (2015): 415-23. doi: https://doi.org/10.1002/ccr3.255
Quintela I, Fernandez-Prieto M, Gomez-Guerrero L, Resches M, Eiris J, Barros F, Carracedo A. A 6q14.1-q15 microdeletion in a male patient with severe autistic disorder, lack of oral language, and dysmorphic features with concomitant presence of a maternally inherited Xp22.31 copy number gain. Clin Case Rep. 2015 Jun;3(6):415-23. doi: 10.1002/ccr3.255. Epub 2015 Apr 09. PMID: 26185640; PMCID: PMC4498854.
Copy Download .nbib Format: NLM
Y chromosome specific polymorphisms in forensic analysis.

Legal medicine (Tokyo, Japan)

Gusmão L, Brion M, González-Neira A, Lareu M, Carracedo A.
PMID: 12935495
Leg Med (Tokyo). 1999 Apr;1(2):55-60. doi: 10.1016/s1344-6223(99)80013-3.

Human Y chromosome polymorphisms are increasingly interesting, not only for population genetics or evolutionary studies but also for forensics. The state of the art on this subject is reviewed in this paper and the types of Y polymorphisms and...

Cite
Gusmão L, Brion M, González-Neira A, et al. Y chromosome specific polymorphisms in forensic analysis. Leg Med (Tokyo). 1999;1(2):55-60doi: 10.1016/s1344-6223(99)80013-3.
Gusmão, L., Brion, M., González-Neira, A., Lareu, M., & Carracedo, A. (1999). Y chromosome specific polymorphisms in forensic analysis. Legal medicine (Tokyo, Japan), 1(2), 55-60. https://doi.org/10.1016/s1344-6223(99)80013-3
Gusmão, L, et al. "Y chromosome specific polymorphisms in forensic analysis." Legal medicine (Tokyo, Japan) vol. 1,2 (1999): 55-60. doi: https://doi.org/10.1016/s1344-6223(99)80013-3
Gusmão L, Brion M, González-Neira A, Lareu M, Carracedo A. Y chromosome specific polymorphisms in forensic analysis. Leg Med (Tokyo). 1999 Apr;1(2):55-60. doi: 10.1016/s1344-6223(99)80013-3. PMID: 12935495.
Copy Download .nbib Format: NLM
An overview of STRUCTURE: applications, parameter settings, and supporting software.

Frontiers in genetics

Porras-Hurtado L, Ruiz Y, Santos C, Phillips C, Carracedo A, Lareu MV.
PMID: 23755071
Front Genet. 2013 May 29;4:98. doi: 10.3389/fgene.2013.00098. eCollection 2013.

OBJECTIVES: We present an up-to-date review of STRUCTURE software: one of the most widely used population analysis tools that allows researchers to assess patterns of genetic structure in a set of samples. STRUCTURE can identify subsets of the whole...

Cite
Porras-Hurtado L, Ruiz Y, Santos C, et al. An overview of STRUCTURE: applications, parameter settings, and supporting software. Front Genet. 2013;4:98doi: 10.3389/fgene.2013.00098.
Porras-Hurtado, L., Ruiz, Y., Santos, C., Phillips, C., Carracedo, A., & Lareu, M. V. (2013). An overview of STRUCTURE: applications, parameter settings, and supporting software. Frontiers in genetics, 498. https://doi.org/10.3389/fgene.2013.00098
Porras-Hurtado, Liliana, et al. "An overview of STRUCTURE: applications, parameter settings, and supporting software." Frontiers in genetics vol. 4 (2013): 98. doi: https://doi.org/10.3389/fgene.2013.00098
Porras-Hurtado L, Ruiz Y, Santos C, Phillips C, Carracedo A, Lareu MV. An overview of STRUCTURE: applications, parameter settings, and supporting software. Front Genet. 2013 May 29;4:98. doi: 10.3389/fgene.2013.00098. eCollection 2013. PMID: 23755071; PMCID: PMC3665925.
Copy Download .nbib Format: NLM
PML: Not all about Tumor Suppression.

Frontiers in oncology

Martin-Martin N, Sutherland JD, Carracedo A.
PMID: 23936764
Front Oncol. 2013 Aug 05;3:200. doi: 10.3389/fonc.2013.00200. eCollection 2013.

No abstract available.

Cite
Martin-Martin N, Sutherland JD, Carracedo A. PML: Not all about Tumor Suppression. Front Oncol. 2013;3:200doi: 10.3389/fonc.2013.00200.
Martin-Martin, N., Sutherland, J. D., & Carracedo, A. (2013). PML: Not all about Tumor Suppression. Frontiers in oncology, 3200. https://doi.org/10.3389/fonc.2013.00200
Martin-Martin, Natalia, et al. "PML: Not all about Tumor Suppression." Frontiers in oncology vol. 3 (2013): 200. doi: https://doi.org/10.3389/fonc.2013.00200
Martin-Martin N, Sutherland JD, Carracedo A. PML: Not all about Tumor Suppression. Front Oncol. 2013 Aug 05;3:200. doi: 10.3389/fonc.2013.00200. eCollection 2013. PMID: 23936764; PMCID: PMC3732998.
Copy Download .nbib Format: NLM
Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients.

Personalized medicine

Aspiroz EL, Cabrera Figueroa SE, Cruz R, Porras Hurtado GL, Martín AF, Hurlé AD, Carracedo A, Team TT.
PMID: 29764065
Per Med. 2014 May;11(3):263-272. doi: 10.2217/pme.14.7.

AIMS: We present a genetic association study in 106 European HIV-infected individuals aimed at identifying and confirming polymorphisms that have a significant influence on toxicity derived from treatment with lopinavir/ritonavir (LPV/r).PATIENTS & METHODS: Genotyping was performed by matrix-assisted laser...

Cite
Aspiroz EL, Cabrera Figueroa SE, Cruz R, et al. Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients. Per Med. 2014;11(3):263-272doi: 10.2217/pme.14.7.
Aspiroz, E. L., Cabrera Figueroa, S. E., Cruz, R., Porras Hurtado, G. L., Martín, A. F., Hurlé, A. D., Carracedo, A., & Team, T. T. (2014). Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients. Personalized medicine, 11(3), 263-272. https://doi.org/10.2217/pme.14.7
Aspiroz, Elena López, et al. "Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients." Personalized medicine vol. 11,3 (2014): 263-272. doi: https://doi.org/10.2217/pme.14.7
Aspiroz EL, Cabrera Figueroa SE, Cruz R, Porras Hurtado GL, Martín AF, Hurlé AD, Carracedo A, Team TT. Toxicogenetics of lopinavir/ritonavir in HIV-infected European patients. Per Med. 2014 May;11(3):263-272. doi: 10.2217/pme.14.7. PMID: 29764065.
Copy Download .nbib Format: NLM
Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer.

Nature genetics

Chen J, Guccini I, Di Mitri D, Brina D, Revandkar A, Sarti M, Pasquini E, Alajati A, Pinton S, Losa M, Civenni G, Catapano CV, Sgrignani J, Cavalli A, D'Antuono R, Asara JM, Morandi A, Chiarugi P, Crotti S, Agostini M, Montopoli M, Masgras I, Rasola A, Garcia-Escudero R, Delaleu N, Rinaldi A, Bertoni F, de Bono J, Carracedo A, Alimonti A.
PMID: 30089860
Nat Genet. 2018 Sep;50(9):1343. doi: 10.1038/s41588-018-0181-1.

In the HTML version of this article initially published, the name of author Diletta Di Mitri was miscoded in the XML such that Di was included as part of the given name instead of the family name. The error...

Cite
Chen J, Guccini I, Di Mitri D, et al. Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat Genet. 2018;50(9):1343doi: 10.1038/s41588-018-0181-1.
Chen, J., Guccini, I., Di Mitri, D., Brina, D., Revandkar, A., Sarti, M., Pasquini, E., Alajati, A., Pinton, S., Losa, M., Civenni, G., Catapano, C. V., Sgrignani, J., Cavalli, A., D'Antuono, R., Asara, J. M., Morandi, A., Chiarugi, P., Crotti, S., Agostini, M., Montopoli, M., Masgras, I., Rasola, A., Garcia-Escudero, R., Delaleu, N., Rinaldi, A., Bertoni, F., de Bono, J., Carracedo, A., & Alimonti, A. (2018). Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nature genetics, 50(9), 1343. https://doi.org/10.1038/s41588-018-0181-1
Chen, Jingjing, et al. "Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer." Nature genetics vol. 50,9 (2018): 1343. doi: https://doi.org/10.1038/s41588-018-0181-1
Chen J, Guccini I, Di Mitri D, Brina D, Revandkar A, Sarti M, Pasquini E, Alajati A, Pinton S, Losa M, Civenni G, Catapano CV, Sgrignani J, Cavalli A, D'Antuono R, Asara JM, Morandi A, Chiarugi P, Crotti S, Agostini M, Montopoli M, Masgras I, Rasola A, Garcia-Escudero R, Delaleu N, Rinaldi A, Bertoni F, de Bono J, Carracedo A, Alimonti A. Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer. Nat Genet. 2018 Sep;50(9):1343. doi: 10.1038/s41588-018-0181-1. PMID: 30089860.
Copy Download .nbib Format: NLM
Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.

PloS one

Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Sertić J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP.
PMID: 28207884
PLoS One. 2017 Feb 16;12(2):e0172595. doi: 10.1371/journal.pone.0172595. eCollection 2017.

[This corrects the article DOI: 10.1371/journal.pone.0162866.].

Cite
Mizzi C, Dalabira E, Kumuthini J, et al. Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One. 2017;12(2):e0172595doi: 10.1371/journal.pone.0172595.
Mizzi, C., Dalabira, E., Kumuthini, J., Dzimiri, N., Balogh, I., Başak, N., Böhm, R., Borg, J., Borgiani, P., Bozina, N., Bruckmueller, H., Burzynska, B., Carracedo, A., Cascorbi, I., Deltas, C., Dolzan, V., Fenech, A., Grech, G., Kasiulevicius, V., Kádaši, �. �., Kučinskas, V., Khusnutdinova, E., Loukas, Y. L., Macek, M., Makukh, H., Mathijssen, R., Mitropoulos, K., Mitropoulou, C., Novelli, G., Papantoni, I., Pavlovic, S., Saglio, G., Sertić, J., Stojiljkovic, M., Stubbs, A. P., Squassina, A., Torres, M., Turnovec, M., van Schaik, R. H., Voskarides, K., Wakil, S. M., Werk, A., Del Zompo, M., Zukic, B., Katsila, T., Lee, M. T., Motsinger-Rief, A., Mc Leod, H. L., van der Spek, P. J., & Patrinos, G. P. (2017). Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PloS one, 12(2), e0172595. https://doi.org/10.1371/journal.pone.0172595
Mizzi, Clint, et al. "Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics." PloS one vol. 12,2 (2017): e0172595. doi: https://doi.org/10.1371/journal.pone.0172595
Mizzi C, Dalabira E, Kumuthini J, Dzimiri N, Balogh I, Başak N, Böhm R, Borg J, Borgiani P, Bozina N, Bruckmueller H, Burzynska B, Carracedo A, Cascorbi I, Deltas C, Dolzan V, Fenech A, Grech G, Kasiulevicius V, Kádaši Ľ, Kučinskas V, Khusnutdinova E, Loukas YL, Macek M, Makukh H, Mathijssen R, Mitropoulos K, Mitropoulou C, Novelli G, Papantoni I, Pavlovic S, Saglio G, Sertić J, Stojiljkovic M, Stubbs AP, Squassina A, Torres M, Turnovec M, van Schaik RH, Voskarides K, Wakil SM, Werk A, Del Zompo M, Zukic B, Katsila T, Lee MT, Motsinger-Rief A, Mc Leod HL, van der Spek PJ, Patrinos GP. Correction: A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics. PLoS One. 2017 Feb 16;12(2):e0172595. doi: 10.1371/journal.pone.0172595. eCollection 2017. PMID: 28207884; PMCID: PMC5313168.
Copy Download .nbib Format: NLM
Forensic SNP genotyping with SNaPshot: Technical considerations for the development and optimization of multiplexed SNP assays.

Forensic science review

Fondevila M, Børsting C, Phillips C, de la Puente M, Consortium EN, Carracedo A, Morling N, Lareu MV.
PMID: 28119267
Forensic Sci Rev. 2017 Jan;29(1):57-76.

This review explores the key factors that influence the optimization, routine use, and profile interpretation of the SNaPshot single-base extension (SBE) system applied to forensic single-nucleotide polymorphism (SNP) genotyping. Despite being a mainly complimentary DNA genotyping technique to routine...

Cite
Fondevila M, Børsting C, Phillips C, et al. Forensic SNP genotyping with SNaPshot: Technical considerations for the development and optimization of multiplexed SNP assays. Forensic Sci Rev. 2017;29(1):57-76
Fondevila, M., Børsting, C., Phillips, C., de la Puente, M., Consortium, E. N., Carracedo, A., Morling, N., & Lareu, M. V. (2017). Forensic SNP genotyping with SNaPshot: Technical considerations for the development and optimization of multiplexed SNP assays. Forensic science review, 29(1), 57-76.
Fondevila, M, et al. "Forensic SNP genotyping with SNaPshot: Technical considerations for the development and optimization of multiplexed SNP assays." Forensic science review vol. 29,1 (2017): 57-76.
Fondevila M, Børsting C, Phillips C, de la Puente M, Consortium EN, Carracedo A, Morling N, Lareu MV. Forensic SNP genotyping with SNaPshot: Technical considerations for the development and optimization of multiplexed SNP assays. Forensic Sci Rev. 2017 Jan;29(1):57-76. PMID: 28119267.
Copy Download .nbib Format: NLM
Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia.

Frontiers in pharmacology

Artiach G, Carracedo M, Clària J, Laguna-Fernandez A, Bäck M.
PMID: 30515096
Front Pharmacol. 2018 Nov 20;9:1327. doi: 10.3389/fphar.2018.01327. eCollection 2018.

Intimal hyperplasia remains a significant clinical problem in for example coronary artery bypass graft failure. Since omega-3 fatty acids reduce intimal hyperplasia, we hypothesized that the G protein-coupled receptor ChemR23 for the omega-3-derived pro-resolving lipid mediator resolvin E1 drives...

Cite
Artiach G, Carracedo M, Clària J, et al. Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia. Front Pharmacol. 2018;9:1327doi: 10.3389/fphar.2018.01327.
Artiach, G., Carracedo, M., Clària, J., Laguna-Fernandez, A., & Bäck, M. (2018). Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia. Frontiers in pharmacology, 91327. https://doi.org/10.3389/fphar.2018.01327
Artiach, Gonzalo, et al. "Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia." Frontiers in pharmacology vol. 9 (2018): 1327. doi: https://doi.org/10.3389/fphar.2018.01327
Artiach G, Carracedo M, Clària J, Laguna-Fernandez A, Bäck M. Opposing Effects on Vascular Smooth Muscle Cell Proliferation and Macrophage-induced Inflammation Reveal a Protective Role for the Proresolving Lipid Mediator Receptor ChemR23 in Intimal Hyperplasia. Front Pharmacol. 2018 Nov 20;9:1327. doi: 10.3389/fphar.2018.01327. eCollection 2018. PMID: 30515096; PMCID: PMC6255922.
Copy Download .nbib Format: NLM
Novel Gene-Based Analysis of ASD GWAS: Insight Into the Biological Role of Associated Genes.

Frontiers in genetics

Alonso-Gonzalez A, Calaza M, Rodriguez-Fontenla C, Carracedo A.
PMID: 31447886
Front Genet. 2019 Aug 09;10:733. doi: 10.3389/fgene.2019.00733. eCollection 2019.

No abstract available.

Cite
Alonso-Gonzalez A, Calaza M, Rodriguez-Fontenla C, et al. Novel Gene-Based Analysis of ASD GWAS: Insight Into the Biological Role of Associated Genes. Front Genet. 2019;10:733doi: 10.3389/fgene.2019.00733.
Alonso-Gonzalez, A., Calaza, M., Rodriguez-Fontenla, C., & Carracedo, A. (2019). Novel Gene-Based Analysis of ASD GWAS: Insight Into the Biological Role of Associated Genes. Frontiers in genetics, 10733. https://doi.org/10.3389/fgene.2019.00733
Alonso-Gonzalez, Aitana, et al. "Novel Gene-Based Analysis of ASD GWAS: Insight Into the Biological Role of Associated Genes." Frontiers in genetics vol. 10 (2019): 733. doi: https://doi.org/10.3389/fgene.2019.00733
Alonso-Gonzalez A, Calaza M, Rodriguez-Fontenla C, Carracedo A. Novel Gene-Based Analysis of ASD GWAS: Insight Into the Biological Role of Associated Genes. Front Genet. 2019 Aug 09;10:733. doi: 10.3389/fgene.2019.00733. eCollection 2019. PMID: 31447886; PMCID: PMC6696953.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 151 entries